Global Adalimumab Biosimilar Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Adalimumab Biosimilar market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Adalimumab Biosimilar market are covered in Chapter 9:
Sandoz
Zydus Cadila
Oncobiologics
Samsung Bioepsis
Boehringer Ingelheim
Pfizer
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
Momenta Pharmaceuticals
Amgen
LG Life Sciences/Mochida Pharmaceutical
AET BioTech
In Chapter 5 and Chapter 7.3, based on types, the Adalimumab Biosimilar market from 2017 to 2027 is primarily split into:
Exemptia
Adalirel
Cipleumab
Others
In Chapter 6 and Chapter 7.4, based on applications, the Adalimumab Biosimilar market from 2017 to 2027 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Adalimumab Biosimilar market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Adalimumab Biosimilar Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ADALIMUMAB BIOSIMILAR MARKET OVERVIEW
1.1 Product Overview and Scope of Adalimumab Biosimilar Market
1.2 Adalimumab Biosimilar Market Segment by Type
1.2.1 Global Adalimumab Biosimilar Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Adalimumab Biosimilar Market Segment by Application
1.3.1 Adalimumab Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Adalimumab Biosimilar Market, Region Wise (2017-2027)
1.4.1 Global Adalimumab Biosimilar Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.3 Europe Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.4 China Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.5 Japan Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.6 India Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.8 Latin America Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.5 Global Market Size of Adalimumab Biosimilar (2017-2027)
1.5.1 Global Adalimumab Biosimilar Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Adalimumab Biosimilar Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Adalimumab Biosimilar Market
2 INDUSTRY OUTLOOK
2.1 Adalimumab Biosimilar Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Adalimumab Biosimilar Market Drivers Analysis
2.4 Adalimumab Biosimilar Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Adalimumab Biosimilar Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Adalimumab Biosimilar Industry Development
3 GLOBAL ADALIMUMAB BIOSIMILAR MARKET LANDSCAPE BY PLAYER
3.1 Global Adalimumab Biosimilar Sales Volume and Share by Player (2017-2022)
3.2 Global Adalimumab Biosimilar Revenue and Market Share by Player (2017-2022)
3.3 Global Adalimumab Biosimilar Average Price by Player (2017-2022)
3.4 Global Adalimumab Biosimilar Gross Margin by Player (2017-2022)
3.5 Adalimumab Biosimilar Market Competitive Situation and Trends
3.5.1 Adalimumab Biosimilar Market Concentration Rate
3.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ADALIMUMAB BIOSIMILAR SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Adalimumab Biosimilar Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Adalimumab Biosimilar Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Adalimumab Biosimilar Market Under COVID-19
4.5 Europe Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Adalimumab Biosimilar Market Under COVID-19
4.6 China Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Adalimumab Biosimilar Market Under COVID-19
4.7 Japan Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Adalimumab Biosimilar Market Under COVID-19
4.8 India Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Adalimumab Biosimilar Market Under COVID-19
4.9 Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Adalimumab Biosimilar Market Under COVID-19
4.10 Latin America Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Adalimumab Biosimilar Market Under COVID-19
4.11 Middle East and Africa Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Adalimumab Biosimilar Market Under COVID-19
5 GLOBAL ADALIMUMAB BIOSIMILAR SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Adalimumab Biosimilar Sales Volume and Market Share by Type (2017-2022)
5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2017-2022)
5.3 Global Adalimumab Biosimilar Price by Type (2017-2022)
5.4 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Exemptia (2017-2022)
5.4.2 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Adalirel (2017-2022)
5.4.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Cipleumab (2017-2022)
5.4.4 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL ADALIMUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION
6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2017-2022)
6.2 Global Adalimumab Biosimilar Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Adalimumab Biosimilar Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Adalimumab Biosimilar Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
6.3.2 Global Adalimumab Biosimilar Consumption and Growth Rate of Retail Pharmacy (2017-2022)
6.3.3 Global Adalimumab Biosimilar Consumption and Growth Rate of Online Pharmacy (2017-2022)
7 GLOBAL ADALIMUMAB BIOSIMILAR MARKET FORECAST (2022-2027)
7.1 Global Adalimumab Biosimilar Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2022-2027)
7.2 Global Adalimumab Biosimilar Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Adalimumab Biosimilar Revenue and Growth Rate of Exemptia (2022-2027)
7.3.2 Global Adalimumab Biosimilar Revenue and Growth Rate of Adalirel (2022-2027)
7.3.3 Global Adalimumab Biosimilar Revenue and Growth Rate of Cipleumab (2022-2027)
7.3.4 Global Adalimumab Biosimilar Revenue and Growth Rate of Others (2022-2027)
7.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2022-2027)
7.4.1 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Hospital Pharmacy(2022-2027)
7.4.2 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Retail Pharmacy(2022-2027)
7.4.3 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Online Pharmacy(2022-2027)
7.5 Adalimumab Biosimilar Market Forecast Under COVID-19
8 ADALIMUMAB BIOSIMILAR MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Adalimumab Biosimilar Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Adalimumab Biosimilar Analysis
8.6 Major Downstream Buyers of Adalimumab Biosimilar Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Adalimumab Biosimilar Industry
9 PLAYERS PROFILES
9.1 Sandoz
9.1.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.1.3 Sandoz Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Zydus Cadila
9.2.1 Zydus Cadila Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.2.3 Zydus Cadila Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Oncobiologics
9.3.1 Oncobiologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.3.3 Oncobiologics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Samsung Bioepsis
9.4.1 Samsung Bioepsis Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.4.3 Samsung Bioepsis Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.5.3 Boehringer Ingelheim Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Pfizer
9.6.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.6.3 Pfizer Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Coherus Biosciences
9.7.1 Coherus Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.7.3 Coherus Biosciences Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Fujifilm Kyowa Kirin Biologics
9.8.1 Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.8.3 Fujifilm Kyowa Kirin Biologics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Momenta Pharmaceuticals
9.9.1 Momenta Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.9.3 Momenta Pharmaceuticals Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Amgen
9.10.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.10.3 Amgen Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 LG Life Sciences/Mochida Pharmaceutical
9.11.1 LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.11.3 LG Life Sciences/Mochida Pharmaceutical Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 AET BioTech
9.12.1 AET BioTech Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.12.3 AET BioTech Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Adalimumab Biosimilar Market
1.2 Adalimumab Biosimilar Market Segment by Type
1.2.1 Global Adalimumab Biosimilar Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Adalimumab Biosimilar Market Segment by Application
1.3.1 Adalimumab Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Adalimumab Biosimilar Market, Region Wise (2017-2027)
1.4.1 Global Adalimumab Biosimilar Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.3 Europe Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.4 China Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.5 Japan Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.6 India Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.8 Latin America Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Adalimumab Biosimilar Market Status and Prospect (2017-2027)
1.5 Global Market Size of Adalimumab Biosimilar (2017-2027)
1.5.1 Global Adalimumab Biosimilar Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Adalimumab Biosimilar Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Adalimumab Biosimilar Market
2 INDUSTRY OUTLOOK
2.1 Adalimumab Biosimilar Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Adalimumab Biosimilar Market Drivers Analysis
2.4 Adalimumab Biosimilar Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Adalimumab Biosimilar Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Adalimumab Biosimilar Industry Development
3 GLOBAL ADALIMUMAB BIOSIMILAR MARKET LANDSCAPE BY PLAYER
3.1 Global Adalimumab Biosimilar Sales Volume and Share by Player (2017-2022)
3.2 Global Adalimumab Biosimilar Revenue and Market Share by Player (2017-2022)
3.3 Global Adalimumab Biosimilar Average Price by Player (2017-2022)
3.4 Global Adalimumab Biosimilar Gross Margin by Player (2017-2022)
3.5 Adalimumab Biosimilar Market Competitive Situation and Trends
3.5.1 Adalimumab Biosimilar Market Concentration Rate
3.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ADALIMUMAB BIOSIMILAR SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Adalimumab Biosimilar Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Adalimumab Biosimilar Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Adalimumab Biosimilar Market Under COVID-19
4.5 Europe Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Adalimumab Biosimilar Market Under COVID-19
4.6 China Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Adalimumab Biosimilar Market Under COVID-19
4.7 Japan Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Adalimumab Biosimilar Market Under COVID-19
4.8 India Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Adalimumab Biosimilar Market Under COVID-19
4.9 Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Adalimumab Biosimilar Market Under COVID-19
4.10 Latin America Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Adalimumab Biosimilar Market Under COVID-19
4.11 Middle East and Africa Adalimumab Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Adalimumab Biosimilar Market Under COVID-19
5 GLOBAL ADALIMUMAB BIOSIMILAR SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Adalimumab Biosimilar Sales Volume and Market Share by Type (2017-2022)
5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2017-2022)
5.3 Global Adalimumab Biosimilar Price by Type (2017-2022)
5.4 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Exemptia (2017-2022)
5.4.2 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Adalirel (2017-2022)
5.4.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Cipleumab (2017-2022)
5.4.4 Global Adalimumab Biosimilar Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL ADALIMUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION
6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2017-2022)
6.2 Global Adalimumab Biosimilar Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Adalimumab Biosimilar Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Adalimumab Biosimilar Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
6.3.2 Global Adalimumab Biosimilar Consumption and Growth Rate of Retail Pharmacy (2017-2022)
6.3.3 Global Adalimumab Biosimilar Consumption and Growth Rate of Online Pharmacy (2017-2022)
7 GLOBAL ADALIMUMAB BIOSIMILAR MARKET FORECAST (2022-2027)
7.1 Global Adalimumab Biosimilar Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2022-2027)
7.2 Global Adalimumab Biosimilar Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Adalimumab Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Adalimumab Biosimilar Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Adalimumab Biosimilar Revenue and Growth Rate of Exemptia (2022-2027)
7.3.2 Global Adalimumab Biosimilar Revenue and Growth Rate of Adalirel (2022-2027)
7.3.3 Global Adalimumab Biosimilar Revenue and Growth Rate of Cipleumab (2022-2027)
7.3.4 Global Adalimumab Biosimilar Revenue and Growth Rate of Others (2022-2027)
7.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2022-2027)
7.4.1 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Hospital Pharmacy(2022-2027)
7.4.2 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Retail Pharmacy(2022-2027)
7.4.3 Global Adalimumab Biosimilar Consumption Value and Growth Rate of Online Pharmacy(2022-2027)
7.5 Adalimumab Biosimilar Market Forecast Under COVID-19
8 ADALIMUMAB BIOSIMILAR MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Adalimumab Biosimilar Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Adalimumab Biosimilar Analysis
8.6 Major Downstream Buyers of Adalimumab Biosimilar Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Adalimumab Biosimilar Industry
9 PLAYERS PROFILES
9.1 Sandoz
9.1.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.1.3 Sandoz Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Zydus Cadila
9.2.1 Zydus Cadila Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.2.3 Zydus Cadila Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Oncobiologics
9.3.1 Oncobiologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.3.3 Oncobiologics Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Samsung Bioepsis
9.4.1 Samsung Bioepsis Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.4.3 Samsung Bioepsis Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.5.3 Boehringer Ingelheim Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Pfizer
9.6.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.6.3 Pfizer Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Coherus Biosciences
9.7.1 Coherus Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.7.3 Coherus Biosciences Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Fujifilm Kyowa Kirin Biologics
9.8.1 Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.8.3 Fujifilm Kyowa Kirin Biologics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Momenta Pharmaceuticals
9.9.1 Momenta Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.9.3 Momenta Pharmaceuticals Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Amgen
9.10.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.10.3 Amgen Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 LG Life Sciences/Mochida Pharmaceutical
9.11.1 LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.11.3 LG Life Sciences/Mochida Pharmaceutical Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 AET BioTech
9.12.1 AET BioTech Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Adalimumab Biosimilar Product Profiles, Application and Specification
9.12.3 AET BioTech Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Adalimumab Biosimilar Product Picture
Table Global Adalimumab Biosimilar Market Sales Volume and CAGR (%) Comparison by Type
Table Adalimumab Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Adalimumab Biosimilar Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Adalimumab Biosimilar Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Adalimumab Biosimilar Industry Development
Table Global Adalimumab Biosimilar Sales Volume by Player (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume Share by Player (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Share by Player in 2021
Table Adalimumab Biosimilar Revenue (Million USD) by Player (2017-2022)
Table Adalimumab Biosimilar Revenue Market Share by Player (2017-2022)
Table Adalimumab Biosimilar Price by Player (2017-2022)
Table Adalimumab Biosimilar Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Adalimumab Biosimilar Sales Volume, Region Wise (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share, Region Wise in 2021
Table Global Adalimumab Biosimilar Revenue (Million USD), Region Wise (2017-2022)
Table Global Adalimumab Biosimilar Revenue Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share, Region Wise in 2021
Table Global Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume by Type (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume Market Share by Type (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share by Type in 2021
Table Global Adalimumab Biosimilar Revenue (Million USD) by Type (2017-2022)
Table Global Adalimumab Biosimilar Revenue Market Share by Type (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share by Type in 2021
Table Adalimumab Biosimilar Price by Type (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Exemptia (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Exemptia (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Adalirel (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Adalirel (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Cipleumab (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Cipleumab (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Adalimumab Biosimilar Consumption by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption Market Share by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption Revenue Market Share by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
Table Global Adalimumab Biosimilar Consumption and Growth Rate of Retail Pharmacy (2017-2022)
Table Global Adalimumab Biosimilar Consumption and Growth Rate of Online Pharmacy (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Adalimumab Biosimilar Price and Trend Forecast (2022-2027)
Figure USA Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Adalimumab Biosimilar Market Sales Volume Forecast, by Type
Table Global Adalimumab Biosimilar Sales Volume Market Share Forecast, by Type
Table Global Adalimumab Biosimilar Market Revenue (Million USD) Forecast, by Type
Table Global Adalimumab Biosimilar Revenue Market Share Forecast, by Type
Table Global Adalimumab Biosimilar Price Forecast, by Type
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Exemptia (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Exemptia (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Adalirel (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Adalirel (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Cipleumab (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Cipleumab (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Adalimumab Biosimilar Market Consumption Forecast, by Application
Table Global Adalimumab Biosimilar Consumption Market Share Forecast, by Application
Table Global Adalimumab Biosimilar Market Revenue (Million USD) Forecast, by Application
Table Global Adalimumab Biosimilar Revenue Market Share Forecast, by Application
Figure Global Adalimumab Biosimilar Consumption Value (Million USD) and Growth Rate of Hospital Pharmacy (2022-2027)
Figure Global Adalimumab Biosimilar Consumption Value (Million USD) and Growth Rate of Retail Pharmacy (2022-2027)
Figure Global Adalimumab Biosimilar Consumption Value (Million USD) and Growth Rate of Online Pharmacy (2022-2027)
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sandoz Profile
Table Sandoz Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Zydus Cadila Profile
Table Zydus Cadila Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zydus Cadila Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Zydus Cadila Revenue (Million USD) Market Share 2017-2022
Table Oncobiologics Profile
Table Oncobiologics Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Oncobiologics Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Oncobiologics Revenue (Million USD) Market Share 2017-2022
Table Samsung Bioepsis Profile
Table Samsung Bioepsis Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Samsung Bioepsis Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Samsung Bioepsis Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Coherus Biosciences Profile
Table Coherus Biosciences Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Coherus Biosciences Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Coherus Biosciences Revenue (Million USD) Market Share 2017-2022
Table Fujifilm Kyowa Kirin Biologics Profile
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Fujifilm Kyowa Kirin Biologics Revenue (Million USD) Market Share 2017-2022
Table Momenta Pharmaceuticals Profile
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Momenta Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table LG Life Sciences/Mochida Pharmaceutical Profile
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Volume and Growth Rate
Figure LG Life Sciences/Mochida Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table AET BioTech Profile
Table AET BioTech Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AET BioTech Adalimumab Biosimilar Sales Volume and Growth Rate
Figure AET BioTech Revenue (Million USD) Market Share 2017-2022
Figure Adalimumab Biosimilar Product Picture
Table Global Adalimumab Biosimilar Market Sales Volume and CAGR (%) Comparison by Type
Table Adalimumab Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Adalimumab Biosimilar Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Adalimumab Biosimilar Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Adalimumab Biosimilar Industry Development
Table Global Adalimumab Biosimilar Sales Volume by Player (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume Share by Player (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Share by Player in 2021
Table Adalimumab Biosimilar Revenue (Million USD) by Player (2017-2022)
Table Adalimumab Biosimilar Revenue Market Share by Player (2017-2022)
Table Adalimumab Biosimilar Price by Player (2017-2022)
Table Adalimumab Biosimilar Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Adalimumab Biosimilar Sales Volume, Region Wise (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share, Region Wise in 2021
Table Global Adalimumab Biosimilar Revenue (Million USD), Region Wise (2017-2022)
Table Global Adalimumab Biosimilar Revenue Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share, Region Wise in 2021
Table Global Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume by Type (2017-2022)
Table Global Adalimumab Biosimilar Sales Volume Market Share by Type (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume Market Share by Type in 2021
Table Global Adalimumab Biosimilar Revenue (Million USD) by Type (2017-2022)
Table Global Adalimumab Biosimilar Revenue Market Share by Type (2017-2022)
Figure Global Adalimumab Biosimilar Revenue Market Share by Type in 2021
Table Adalimumab Biosimilar Price by Type (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Exemptia (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Exemptia (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Adalirel (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Adalirel (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Cipleumab (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Cipleumab (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Adalimumab Biosimilar Consumption by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption Market Share by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption Revenue Market Share by Application (2017-2022)
Table Global Adalimumab Biosimilar Consumption and Growth Rate of Hospital Pharmacy (2017-2022)
Table Global Adalimumab Biosimilar Consumption and Growth Rate of Retail Pharmacy (2017-2022)
Table Global Adalimumab Biosimilar Consumption and Growth Rate of Online Pharmacy (2017-2022)
Figure Global Adalimumab Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Adalimumab Biosimilar Price and Trend Forecast (2022-2027)
Figure USA Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Adalimumab Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Adalimumab Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Adalimumab Biosimilar Market Sales Volume Forecast, by Type
Table Global Adalimumab Biosimilar Sales Volume Market Share Forecast, by Type
Table Global Adalimumab Biosimilar Market Revenue (Million USD) Forecast, by Type
Table Global Adalimumab Biosimilar Revenue Market Share Forecast, by Type
Table Global Adalimumab Biosimilar Price Forecast, by Type
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Exemptia (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Exemptia (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Adalirel (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Adalirel (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Cipleumab (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Cipleumab (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Adalimumab Biosimilar Market Consumption Forecast, by Application
Table Global Adalimumab Biosimilar Consumption Market Share Forecast, by Application
Table Global Adalimumab Biosimilar Market Revenue (Million USD) Forecast, by Application
Table Global Adalimumab Biosimilar Revenue Market Share Forecast, by Application
Figure Global Adalimumab Biosimilar Consumption Value (Million USD) and Growth Rate of Hospital Pharmacy (2022-2027)
Figure Global Adalimumab Biosimilar Consumption Value (Million USD) and Growth Rate of Retail Pharmacy (2022-2027)
Figure Global Adalimumab Biosimilar Consumption Value (Million USD) and Growth Rate of Online Pharmacy (2022-2027)
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sandoz Profile
Table Sandoz Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Zydus Cadila Profile
Table Zydus Cadila Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zydus Cadila Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Zydus Cadila Revenue (Million USD) Market Share 2017-2022
Table Oncobiologics Profile
Table Oncobiologics Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Oncobiologics Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Oncobiologics Revenue (Million USD) Market Share 2017-2022
Table Samsung Bioepsis Profile
Table Samsung Bioepsis Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Samsung Bioepsis Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Samsung Bioepsis Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Coherus Biosciences Profile
Table Coherus Biosciences Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Coherus Biosciences Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Coherus Biosciences Revenue (Million USD) Market Share 2017-2022
Table Fujifilm Kyowa Kirin Biologics Profile
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Fujifilm Kyowa Kirin Biologics Revenue (Million USD) Market Share 2017-2022
Table Momenta Pharmaceuticals Profile
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Momenta Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Adalimumab Biosimilar Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table LG Life Sciences/Mochida Pharmaceutical Profile
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Volume and Growth Rate
Figure LG Life Sciences/Mochida Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table AET BioTech Profile
Table AET BioTech Adalimumab Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AET BioTech Adalimumab Biosimilar Sales Volume and Growth Rate
Figure AET BioTech Revenue (Million USD) Market Share 2017-2022
